The University of Houston System's general counsel defended the dual course reviews underway across UH campuses on Thursday, telling the Board of Regents that top administrators chose an approach that ...

Bottom Line: Why Choose UWorld? After spending time inside the platform, UWorld feels the most dialed in for serious ACT repetition and mistake analysis. It keeps everything centered on practice ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Four months after ...

Kesler CPA Review, the CPA review course founded by Bryan Kesler, CPA in 2022, has released its updated 2026 platform covering all six sections of the CPA exam. I’d like to thank Especially, Bryan ...

North Texas public university systems could soon see changes in courses as they review their academic offerings amid a push from state Republican officials to restrict what is taught in classrooms.

The Food and Drug Administration reversed an earlier decision to not review Moderna's flu vaccine and will evaluate the company's modified application for a potential approval, Moderna said on Feb. 18 ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu ...

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA1.62%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...

Moderna said Wednesday the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling ...

Moderna's shares close up 6% Moderna to conduct post-marketing study in older adults FDA decision expected by August 5 Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug ...